RO8191

RO8191 is a small molecule agonist of the interferon (IFN) receptor that acts as a potent activator of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway. Originally identified as an orally active mimic of interferon-alpha, RO8191 binds to the IFN receptor complex, triggering the phosphorylation and activation of Janus kinases (specifically JAK1 and JAK2) and subsequent activation of various STAT proteins, including STAT1, STAT3, and STAT5. In preclinical research, RO8191 is extensively used as a pharmacological tool to study the therapeutic potential of JAK/STAT activation in diverse conditions such as embryo implantation failure, various malignancies (including lung, liver, and glioma), and inflammatory or fibrotic diseases like ulcerative colitis, diabetic nephropathy, and silicosis. It has demonstrated the ability to rescue implantation defects in mouse models and reverse the inhibitory effects of experimental drugs on tumor progression and immune cell polarization.